Zacks Investment Research | Nov 04, 2018 08:08PM ET
BioLife Solutions, Inc.’s (NASDAQ:BLFS) third-quarter 2018 results are scheduled for release on Nov 8, after market close. While the company is likely to gain from biopreservation media products, stiff competition might show on results.
Q2 Results at a Glance
In the last reported quarter, BioLife reported adjusted earnings per share of 5 cents, beating the Zacks Consensus Estimate of 3 cents.
The company reported revenues of $5.2 million, in line with the Zacks Consensus Estimate. Revenues skyrocketed 102% year over year.
BioLife has an average positive earnings surprise of 51.8% for the trailing four quarters.
Which Way Are Estimates Treading for Q3?
For the quarter to be reported, the Zacks Consensus Estimate for earnings is pegged at 4 cents per share, reflecting a whopping increase of 233.3% year over year. The same for revenues is pinned at $5.2 million, indicating growth of 75.2% from the year-ago quarter.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.